Why This Pharmaceutical Stock Jumped Almost 100% This Week
A mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
Compare brokers on index fund selections, focusing on fund variety, fees, and ease of use to pick the best platform for your needs.
28,035 articlesA mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
CrowdStrike has pulled back from recent highs. Before March 3 earnings, investors wonder if a dip offers a real buyin...
War-time disruption in the Middle East drives oil higher and pushes up consumer costs, threatening to accelerate infl...
MP Materials jumped about 30% in a month, signaling growing investor interest in U.S. rare-earth supply. This article...
The AI boom isn’t a one-stock story. Here are three well-positioned names beyond Nvidia that could fuel the next rall...
A Long Island student’s six-word yearbook line predicting the Knicks’ 2026 finals has exploded online, triggering con...
A veteran market commentator shines a light on a legacy chipmaker as a serious AI play. This analysis weighs the case...
Wall Street chatter about a SpaceX and Tesla merger has sparked a wave of questions. This article unpacks what the ph...
When a CEO unloads a big chunk of stock, investors take note. This article digs into sentinelone's sold over 39,000 s...
Bitcoin trades near a critical pivot, with bulls and bears eyeing a breakout above resistance or a renewed pullback. ...
Howard Lindzon’s work with StockTwits and Social Leverage reshapes how we think about investing in communities. This ...
When a founder makes a bold move after a price drop, investors sit up and take notice. This article unpacks what a pu...